RT20 20mg*10vials

Retatrutide RT20 20mg*10vials

Retatrutide is a triple-receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, standing as one of the most potent metabolic research peptides in its class.

The 20mg single-vial specification delivers a higher active ingredient concentration per vial. This makes it ideal for high-dose validation studies, extended large-animal research protocols, and researchers who need fewer vials per experiment to reduce handling variables. The 20mg format minimizes dilution adjustments across long experimental timelines.

Through dual GLP-1 and GIP pathway activation, this compound supports research into insulin sensitivity, glycemic regulation, and appetite-related signaling. The glucagon receptor component adds a third layer of metabolic modulation related to energy expenditure and lipid metabolism.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Every batch undergoes rigorous purity analysis, with a certificate of analysis provided.

10 vials per pack, designed for professional preclinical and laboratory research use.